Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson's disease-like symptoms in Wistar rats
- PMID: 40379880
- DOI: 10.1007/s10534-025-00693-7
Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson's disease-like symptoms in Wistar rats
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra region of the brain. Although iron is one of the essential micronutrients in the brain, its excess exposure and accumulation in the brain substantia nigra and striatum regions may induce critical pathological changes relevant to PD. This study has evaluated neurobehavioral, biochemical, and structural alterations resembling PD-like symptoms induced through a 4-week co-exposure of ferrous sulfate (FeSO4) with lipopolysaccharide (LPS) in Wistar rats. Our results revealed motor deficits, oxidative stress, neuroinflammation, iron dysregulation, protein aggregation, ferroptosis, and apoptotic cell death. Notably, we observed decreased tyrosine hydroxylase levels and increased α-synuclein accumulation, consistent with PD pathology. The immunohistopathological assessments showed astrocyte activation and iron deposition, supporting their roles in neuroinflammation and oxidative stress. Furthermore, we identified alterations in apoptosis and ferroptosis markers, suggesting dose-related involvement of FeSO4 in neuronal death in the rat brain. These findings have highlighted the multifaceted mechanisms during the co-exposure of FeSO4 and LPS-induced neurodegeneration and neuroinflammation relevant to PD. This study emphasizes that therapeutic targeting of these pathological mechanisms may offer a promising therapeutic intervention in PD.
Keywords: Ferroptosis; Iron; Lipopolysaccharide; Neuroinflammation; Parkinson’s disease.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflict of interest. Ethical approval: All the procedures and protocols were approved by the Institutional Animal Ethics Committee (IAEC) of NIPER-Raebareli, Lucknow, India (Protocol Number NIPER/RBL/IAEC/135/June 2023) and used in the experiment as per the provisions laid down by the Committee for Control and Supervision of Experiments on Animals (CCSEA), India. Informed consent: Not applicable.
References
-
- Angelova PR, Choi ML, Berezhnov AV, Horrocks MH, Hughes CD, De S, Rodrigues M, Yapom R, Little D, Dolt KS, Kunath T, Devine MJ, Gissen P, Shchepinov MS, Sylantyev S, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2020) Correction: alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ 27:2747. https://doi.org/10.1038/s41418-020-0552-x - DOI
-
- Antipova V, Holzmann C, Hawlitschka A, Witt M, Wree A (2021) Antidepressant-like properties of intrastriatal botulinum neurotoxin-A injection in a unilateral 6-OHDA rat model of Parkinson’s disease. Toxins. https://doi.org/10.3390/toxins13070505 - DOI
-
- Baral B, Chauhan C, Mishra T, Kaundal RK (2025) Neuroprotective effects of Saxagliptin in traumatic brain injury: ameliorating oxidative stress, neuroinflammation, and apoptosis. Metab Brain Dis 40:175. https://doi.org/10.1007/s11011-025-01584-z - DOI
-
- Beier EE, Neal M, Alam G, Edler M, Wu LJ, Richardson JR (2017) Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis 108:115–127. https://doi.org/10.1016/j.nbd.2017.08.009 - DOI
-
- Boyd RJ, Avramopoulos D, Jantzie LL, McCallion AS (2022) Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. J Neuroinflamm 19:223. https://doi.org/10.1186/s12974-022-02584-x - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
